Marketing-authorisation holder · United States
Actavis Elizabeth
12 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · United States
12 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
12 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ALPRAZOLAM0.25mg | 0.5mg | 1mg | 2mg · Tablet, orally disintegrating | Alprazolam | United States | Marketed | 2009 |
| DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE1.25mg; 1.25mg; 1.25mg; 1.25mg | 1.875mg; 1.875mg; 1.875mg; 1.875mg | 2.5mg; 2.5mg; 2.5mg; 2.5mg | 3.125mg; 3.125mg; 3.125mg; 3.125mg | 3.75mg; 3.75mg; 3.75mg; 3.75mg | 5mg; 5mg; 5mg; 5mg | 7.5mg; 7.5mg; 7.5mg; 7.5mg · Tablet | Amphetamine aspartate, Amfetamine, Dextroamphetamine saccharate, Dexamfetamine | United States | Marketed | 2002 |
| GLYBURIDE AND METFORMIN HYDROCHLORIDE1.25mg; 250mg | 2.5mg; 500mg | 5mg; 500mg · Tablet | Glibenclamide, Metformin | United States | Marketed | 2004 |
| LAMOTRIGINE100mg | 200mg | 250mg | 25mg | 300mg | 50mg · Tablet, extended release | Lamotrigine | United States | Marketed | 2012 |
| METHYLPHENIDATE17.3mg | 25.9mg | 8.6mg · Tablet, orally disintegrating, extended release | Methylphenidate | United States | Marketed | 2020 |
| MIRTAZAPINE15mg | 30mg | 45mg · Tablet, orally disintegrating | Mirtazapine | United States | Marketed | 2003 |
| MORPHINE SULFATE100mg | 10mg | 120mg | 20mg | 30mg | 40mg | 45mg | 50mg | 60mg | 70mg | 75mg | 80mg | 90mg · Capsule, extended release | Morphine | United States | Marketed | 2011 |
| PEMOLINE37.5mg · Tablet, chewable | Pemoline | United States | Not marketed | 2000 |
| PEMOLINE18.75mg | 37.5mg | 75mg · Tablet | Pemoline | United States | Not marketed | 1999 |
| PRAMIPEXOLE DIHYDROCHLORIDE0.375mg | 0.75mg | 1.5mg | 2.25mg | 3.75mg | 3mg | 4.5mg · Tablet, extended release | Pramipexole | United States | Marketed | 2014 |
| TRAMADOL HYDROCHLORIDE100mg | 200mg | 300mg · Tablet, extended release | Tramadol | United States | Marketed | 2009 |
| RANITIDINE15mg/ml · Solution | Ranitidine | United States | tentative | 1997 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 12 | 11 | 1 | CompaniesAll medicines |
The active substances in most of its medicines.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.